Vitamin C suppresses cell death in MCF-7 human breast cancer cells induced by tamoxifen
- PMID: 24266867
- PMCID: PMC3930417
- DOI: 10.1111/jcmm.12188
Vitamin C suppresses cell death in MCF-7 human breast cancer cells induced by tamoxifen
Abstract
Vitamin C is generally thought to enhance immunity and is widely taken as a supplement especially during cancer treatment. Tamoxifen (TAM) has both cytostatic and cytotoxic properties for breast cancer. TAM engaged mitochondrial oestrogen receptor beta in MCF-7 cells and induces apoptosis by activation of pro-caspase-8 followed by downstream events, including an increase in reactive oxygen species and the release of pro-apoptotic factors from the mitochondria. In addition to that, TAM binds with high affinity to the microsomal anti-oestrogen-binding site and inhibits cholesterol esterification at therapeutic doses. This study aimed to investigate the role of vitamin C in TAM-mediated apoptosis. Cells were loaded with vitamin C by exposure to dehydroascorbic acid, thereby circumventing in vitro artefacts associated with the poor transport and pro-oxidant effects of ascorbic acid. Pre-treatment with vitamin C caused a dose-dependent attenuation of cytotoxicity, as measured by acridine-orange/propidium iodide (AO/PI) and Annexin V assay after treatment with TAM. Vitamin C dose-dependently protected cancer cells against lipid peroxidation caused by TAM treatment. By real-time PCR analysis, an impressive increase in FasL and tumour necrosis factor-α (TNF-α) mRNA was detected after TAM treatment. In addition, a decrease in mitochondrial transmembrane potential was observed. These results support the hypothesis that vitamin C supplementation during cancer treatment may detrimentally affect therapeutic response.
Keywords: ROS; apoptosis; breast cancer; free radical; lipid peroxidation; tamoxifen; vitamin C.
© 2013 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Figures
Similar articles
-
Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.Apoptosis. 2005 Dec;10(6):1395-410. doi: 10.1007/s10495-005-2137-z. Apoptosis. 2005. PMID: 16215679
-
Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase.Steroids. 2020 Aug;160:108656. doi: 10.1016/j.steroids.2020.108656. Epub 2020 May 18. Steroids. 2020. PMID: 32439410
-
Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.Int J Oncol. 2013 Dec;43(6):1777-86. doi: 10.3892/ijo.2013.2127. Epub 2013 Oct 4. Int J Oncol. 2013. PMID: 24100375 Free PMC article.
-
Effect of vitamin E on tamoxifen-treated breast cancer cells.Surgery. 2006 Oct;140(4):607-14; discussion 614-5. doi: 10.1016/j.surg.2006.07.007. Epub 2006 Sep 6. Surgery. 2006. PMID: 17011908
-
Identification of Sirtuin 3, a mitochondrial protein deacetylase, as a new contributor to tamoxifen resistance in breast cancer cells.Biochem Pharmacol. 2013 Sep 15;86(6):726-33. doi: 10.1016/j.bcp.2013.06.032. Epub 2013 Jul 12. Biochem Pharmacol. 2013. PMID: 23856293
Cited by
-
Dual-responsive, Methotrexate-loaded, Ascorbic acid-derived Micelles Exert Anti-tumor and Anti-metastatic Effects by Inhibiting NF-κB Signaling in an Orthotopic Mouse Model of Human Choriocarcinoma.Theranostics. 2019 Jun 9;9(15):4354-4374. doi: 10.7150/thno.35125. eCollection 2019. Theranostics. 2019. PMID: 31285766 Free PMC article.
-
Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells.PeerJ. 2021 Oct 27;9:e12124. doi: 10.7717/peerj.12124. eCollection 2021. PeerJ. 2021. PMID: 34760343 Free PMC article.
-
Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.Sci Rep. 2016 Dec 9;6:38787. doi: 10.1038/srep38787. Sci Rep. 2016. PMID: 27934917 Free PMC article.
-
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives.Int J Mol Sci. 2021 Apr 5;22(7):3765. doi: 10.3390/ijms22073765. Int J Mol Sci. 2021. PMID: 33916438 Free PMC article. Review.
-
Tamoxifen and oxidative stress: an overlooked connection.Discov Oncol. 2021 May 27;12(1):17. doi: 10.1007/s12672-021-00411-y. Discov Oncol. 2021. PMID: 35201439 Free PMC article. Review.
References
-
- Baum M. Adjuvant endocrine therapy in postmenopausal women with early breast cancer: where are we now? Eur J Cancer. 2005;41:1667–77. - PubMed
-
- Mandlekar S, Kong AN. Mechanisms of tamoxifen-induced apoptosis. Apoptosis. 2001;6:469–77. - PubMed
-
- Moreira PI, Custodio J, Morena A, et al. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J Biol Chem. 2006;281:10143–52. - PubMed
-
- Han P, Kang JH, Li HL, et al. Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression. Biochem Biophys Res Commun. 2009;385:251–6. - PubMed
-
- Moriai R, Tsuji N, Moriai M, et al. Survivin plays as a resistant factor against taxoxifen-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat. 2009;117:261–71. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous